Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Certified by Founder
Lodge
Rivermark Medical, Inc.
start up
United States
- Milwaukee
- 11/10/2024
- Series C
- $30,000,000
Minimally Invasive Device Therapy for BPH
- Industry Hospital & Health Care
- Website https://www.rivermarkmedical.com/
- LinkedIn https://www.linkedin.com/company/rivermark-medical-inc/
Related People
Adam Kadlec, MD, MBAFounder
United States -
Milwaukee, Wisconsin
As the co-founder and CEO of Rivermark Medical, I am on a mission to improve the lives of millions of men suffering from benign prostatic hyperplasia (BPH).
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)